Experiment 652682
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | EXTERNAL |
| Organism | Empty organism |
| Citation | CHANG,YC: MAIBACH,HI:. (1997). ADVANCES INN DERMATOPHARMACOLOGY- STRENGTH AND WEAKNESS OF RECENTLY APPROVED DRUGS(1).. 35(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN CONTROLLED STUDIES, 20% AZA WAS MARKEDLY MORE EFFECTIVE THAN THAT OF ITS VEHICLE IN REDUCING NUMBERS OF COMEDONES. PAPULES, AND PUSTULES IN PATIENTS WITH MILD TO MODERATE ACNE. AZA ALSO DEMONSTRATED COMPARABLE ANTI-ACNE EFFICACY TO TOPICAL 0.05% TRETINOIN CREAM, TOPICAL 5% BENZOYL PEROXIDE GEL, TOPICAL 2% ERTHROMYCIN CREAM AND ORAL TETRACYCLINE 0.5-1.0 G/DAY IN COMEDONAL AND MILD TO MODERATE INFLAMMATORY ACNE. AZA SHOWED LESS LOCAL SIDE-EFFECTS THAN 5% BENZOYL PEROXIDE GEL AND 0.05% TRETINOIN CREAM. |
| Dose amount | 20.0 |
| Number | 4 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | CONC USED |
| Gender | GIVEN TO BOTH SEXES |